| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Former Cbo | Former Chief Business Officer | Chief Business Officer
1 company
Avat Xavier is a Former Cbo at CAPR. Recent filings cover 2 purchases and 2 sales.
Our model assigns Avat Xavier a below-average insider score of 48/100, based on 4 past trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of -13.5%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 17, 2023 | CAPR Capricor Therapeutics, Inc. | Former Cbo | Sell | 14,772 | $0.00 | - | -100% | +1.9% | +38.2% | |
| Mar 28, 2023 | CAPR Capricor Therapeutics, Inc. | Former Chief Business Officer | Sale+OE | 3,000 | $4.06 | $12,180.00 | -100% | +20.0% | +65.1% | |
| Jul 6, 2022 | CAPR Capricor Therapeutics, Inc. | Chief Business Officer | Buy | 2,500 | $3.73 | $9,322.85 | +100.0% | +72.9% | +21.6% |